Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$15.36 - $27.51 $17.8 Million - $31.8 Million
-1,155,964 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$22.22 - $39.12 $25.7 Million - $45.2 Million
1,155,964 New
1,155,964 $29 Million
Q4 2021

Feb 14, 2022

SELL
$18.38 - $40.5 $4.02 Million - $8.85 Million
-218,532 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$13.18 - $19.83 $43.2 Million - $65 Million
-3,278,107 Reduced 93.75%
218,532 $3.74 Million
Q2 2021

Aug 16, 2021

SELL
$9.59 - $50.88 $577,039 - $3.06 Million
-60,171 Reduced 1.69%
3,496,639 $46.8 Million
Q1 2021

May 17, 2021

SELL
$49.53 - $68.4 $60.4 Million - $83.4 Million
-1,219,738 Reduced 25.54%
3,556,810 $182 Million
Q4 2020

Feb 16, 2021

SELL
$47.25 - $65.16 $2.38 Million - $3.28 Million
-50,362 Reduced 1.04%
4,776,548 $296 Million
Q2 2020

Aug 14, 2020

BUY
$38.58 - $65.07 $25.1 Million - $42.3 Million
650,000 Added 15.56%
4,826,910 $278 Million
Q1 2020

May 15, 2020

BUY
$32.73 - $50.78 $32 Million - $49.6 Million
977,521 Added 30.55%
4,176,910 $168 Million
Q4 2019

Feb 14, 2020

BUY
$6.81 - $39.55 $21.8 Million - $127 Million
3,199,389 New
3,199,389 $127 Million

Others Institutions Holding CCXI

About ChemoCentryx, Inc.


  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Ra Capital Management, L.P. Portfolio

Follow Ra Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Ra Capital Management, L.P. with notifications on news.